Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Journal of Neurovirology|September 1, 1995
Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vectorS D Keir, W J Mitchell, L T Feldman, et al.Journal of Virology|November 23, 2000
Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient miceE Chang, L Galle, D Maggs, et al.Cancer Gene Therapy|February 27, 2010
Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivationM C Whelan, G Casey, M MacConmara, et al.Cancer Immunology, Immunotherapy : CII|April 14, 2006
Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic diseaseM Tangney, G Casey, J O Larkin, et al.Cancer Letters|January 9, 2008
Immune gene therapy as a neoadjuvant to surgical excision to control metastatic cancersJ P Cashman, J O Larkin, G Casey, et al.Letters in Applied Microbiology|October 16, 2004
Isolation and characterization of anti-Salmonella lactic acid bacteria from the porcine gastrointestinal tractP G Casey, G D Casey, G E Gardiner, et al.Archives of Virology|January 1, 1991
Correlation between humoral immune responses and presence of virus in the CNS in dogs experimentally infected with canine distemper virusB K Rima, N Duffy, W J Mitchell, et al.Journal of Virology|November 1, 1990
Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal gangliaW J Mitchell, S L Deshmane, A Dolan, et al.European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Combined electric field and ultrasound therapy as a novel anti-tumour treatmentJ Larkin, D Soden, C Collins, et al.Current Eye Research|June 5, 2002
Increased severity of herpes simplex virus type 1-induced keratitis in Hox A5 transgenic miceL E Galle, N S Taus, D J Maggs, et al.Pageof 9